These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 30908865)
1. H Xu Y; Shi W; Li H; Li X; Ma H ChemMedChem; 2019 Jun; 14(11):1079-1085. PubMed ID: 30908865 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
3. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery. Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830 [TBL] [Abstract][Full Text] [Related]
4. PVA reinforced gossypolone and doxorubicin π-π stacking nanoparticles towards tumor targeting and ultralow dose synergistic chemotherapy. Liu Y; Li K; Wu Y; Ma J; Tang P; Liu Y; Wu D Biomater Sci; 2019 Aug; 7(9):3662-3674. PubMed ID: 31179466 [TBL] [Abstract][Full Text] [Related]
5. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy. Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin. Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383 [TBL] [Abstract][Full Text] [Related]
7. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging. Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Datir SR; Das M; Singh RP; Jain S Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830 [TBL] [Abstract][Full Text] [Related]
9. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer. Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096 [TBL] [Abstract][Full Text] [Related]
10. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy. Zhang Y; Wei C; Lv F; Liu T Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy. Xia Y; Xiao M; Zhao M; Xu T; Guo M; Wang C; Li Y; Zhu B; Liu H Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110100. PubMed ID: 31753388 [TBL] [Abstract][Full Text] [Related]
12. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690 [TBL] [Abstract][Full Text] [Related]
13. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery. Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation. Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124 [TBL] [Abstract][Full Text] [Related]
15. Embedding fluorescent mesoporous silica nanoparticles into biocompatible nanogels for tumor cell imaging and thermo/pH-sensitive in vitro drug release. Gui R; Wang Y; Sun J Colloids Surf B Biointerfaces; 2014 Apr; 116():518-25. PubMed ID: 24576821 [TBL] [Abstract][Full Text] [Related]
16. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593 [TBL] [Abstract][Full Text] [Related]
17. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study. Kumar P; Tambe P; Paknikar KM; Gajbhiye V Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877 [TBL] [Abstract][Full Text] [Related]
18. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086 [TBL] [Abstract][Full Text] [Related]
19. Activatable Fluorescence Imaging and Targeted Drug Delivery via Extracellular Vesicle-Like Porous Coordination Polymer Nanoparticles. Wu Y; Zhang F; Wang K; Luo P; Wei Y; Liu S Anal Chem; 2019 Nov; 91(21):14036-14042. PubMed ID: 31603308 [TBL] [Abstract][Full Text] [Related]
20. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery. Fan J; Zhang Z; Wang Y; Lin S; Yang S J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]